2026 MIPS Measures Relevant to Allergy/Immunology

The 2026 MIPS quality measures CMS lists as relevant to Allergy/Immunology. Pick the highest-scoring set for your practice — our certified consultants can help.

Reporting MIPS for a Allergy/Immunology practice means choosing 6 quality measures — including at least one Outcome or other High Priority measure — and reporting each on as many eligible cases as possible to be scored against CMS's national benchmarks. The measures below are the ones CMS lists as relevant to Allergy/Immunology; open any for its full numerator, denominator, and exclusions.

Showing 12 measures for Allergy/Immunology
High PriorityProcessEHRRegistryNQF: 0419

Percentage of visits for patients aged 18 years and older for which the eligible professional or eligible clinician attests to documenting a list of current medications using all immediate resources available on the date of the encounter. Instructions This measure is to be submitted at…

ProcessEHRRegistryNQF: 0028

Percentage of patients aged 12 years and older who were screened for tobacco use one or more times within the measurement period AND who received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period if identified as…

High PriorityProcessEHRRegistryNQF: 0022

Percentage of patients 65 years of age and older who were ordered at least two high-risk medications from the same drug class. Instructions This measure is to be submitted a minimum of once per performance period for patients seen during the performance period. There is…

ProcessEHRRegistry

Percentage of patient visits for patients aged 18 years and older seen during the performance period who were screened for high blood pressure AND a recommended follow-up plan is documented, as indicated, if blood pressure is elevated or hypertensive. Instructions This measure is to be…

High PriorityProcessRegistry

Percentage of patients, aged 18 years and older, with a diagnosis of acute viral sinusitis who were prescribed an antibiotic within 10 days after onset of symptoms. Instructions This measure may be submitted based on the actions of the submitting Merit-based Incentive Payment System (MIPS)…

High PriorityProcessRegistry

Percentage of patients aged 18 years and older with a diagnosis of acute bacterial sinusitis that were prescribed amoxicillin, with or without clavulanate, as a first line antibiotic at the time of diagnosis. Instructions This measure may be submitted based on the actions of the…

High PriorityOutcomeEHRRegistryNQF: 2082

Percentage of patients, regardless of age, diagnosed with HIV prior to or during the first 90 days of the performance period, with an eligible encounter in the first 240 days of the performance period, whose last HIV viral load test result was less than 200…

High PriorityProcessEHRRegistryNQF: 2079

Percentage of patients, regardless of age, with a diagnosis of Human Immunodeficiency Virus (HIV) before or during the first 240 days of the performance period who had at least two eligible encounters or at least one eligible encounter and one HIV viral load test that…

High PriorityProcessEHRRegistry

Percentage of patients with referrals, regardless of age, for which the referring clinician receives a report from the clinician to whom the patient was referred. Instructions This measure is to be submitted a minimum of once per performance period for denominator eligible cases as defined…

High PriorityOutcomeRegistry

Composite measure of the percentage of pediatric and adult patients whose asthma is well-controlled as demonstrated by one of three age appropriate patient reported outcome tools and not at risk for exacerbation. Instructions This measure is to be submitted a minimum of once per performance…

ProcessRegistryNQF: 3620

Percentage of patients 19 years of age and older who are up-to-date on recommended routine vaccines for influenza; tetanus and diphtheria (Td) or tetanus, diphtheria and acellular pertussis (Tdap); zoster; pneumococcal; and hepatitis B. Instructions This measure is to be submitted a minimum of once…

High PriorityOutcomeRegistryNQF: 2483

The Patient Activation Measure® (PAM®) is a 10- or 13-item questionnaire that assesses an individual´s knowledge, skills, and confidence for managing their health and health care. The measure assesses individuals on a 0-100 scale that converts to one of four levels of activation, from low…

Need help reporting for Allergy/Immunology?

Our AAPC-certified MIPS experts map the highest-scoring measures to your specialty and manage your reporting end-to-end.

Talk to an expert